| Drug Name |
Lercanidipine |
| Drug ID |
BADD_D01255 |
| Description |
Lercanidipine is a calcium channel blocker of the dihydropyridine class. It is sold under various commercial names including Zanidip. |
| Indications and Usage |
For the treatment of Hypertension, management of angina pectoris and Raynaud's syndrome |
| Marketing Status |
approved; investigational |
| ATC Code |
C08CA13 |
| DrugBank ID |
DB00528
|
| KEGG ID |
D08111
|
| MeSH ID |
C060343
|
| PubChem ID |
65866
|
| TTD Drug ID |
D0P6ZH
|
| NDC Product Code |
Not Available |
| UNII |
V7XTJ4R0BH
|
| Synonyms |
lercanidipine | methyl-1,1-dimethyl-2-(N-(3,3-diphenylpropyl)-N-methylamino)ethyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | lercanidipine hydrochloride | Zanidip | Lerdip | Lercadip | REC 15-2375 | REC-15-2375 |
